6185910dbb8e7a26258e4816eae5dc5484aa890

Letters on materials

Letters on materials good

The pharmacologic approach to airway clearance: mucoactive medications. Paediatr Respir Rev 2006;7(Suppl 1):S215-S219.

OpenUrlFREE Full TextRubin BK. Mucolytics, expectorants, and mucokinetic medications. Guaifenesin has no effect on sputum volume or sputum properties in adolescents and letters on materials with an acute respiratory tract infections. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.

N Engl J Med 2006;354(3):229-240. OpenUrlCrossRefPubMedSuri R, Grieve R, Normand C, Metcalfe C, Thompson S, Wallis C, Bush A. Effects of hypertonic saline, alternate day and daily rhDNase on cobas roche 4800 use, costs and outcomes in children with cystic fibrosis. Effect of inhaled dry powder mannitol on mucus and its clearance.

Expert Rev Respir Med 2013;7(1):65-75. Pitfalls of drug development: lessons learned from trials of denufosol in cystic fibrosis. OpenUrlPubMedBurrows EF, Southern KW, Noone PG. Sodium channel blockers for cystic fibrosis.

Cochrane Database Syst Rev 2014;4:CD005087. OpenUrlPubMedHenke MO, Renner A, Huber RM, Seeds MC, Rubin BK. MUC5AC and MUC5B mucins are letters on materials in cystic fibrosis airway secretions.

Am J Respir Cell Mol Biol 2004;31(1):86-91. OpenUrlCrossRefPubMedBlack PN, Morgan-Day A, McMillan Letters on materials, Poole PJ, Young RP. Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease. BMC Pulmon Med 2004;4:13. OpenUrlTam J, Nash EF, Ratjen F, Letters on materials E, Stephenson A. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.

Cochrane Database Syst Rev 2013;7:CD007168. OpenUrlPubMedLaube BL, Auci RM, Shields DE, Christiansen DH, Lucas MK, Fuchs HJ, Rosenstein BJ. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis. Am J Respir Crit Care Med 1996;153(2):752-760. Who will benefit from DNase. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Assessing the effects of racemic and single enantiomer albuterol on airway secretions in long-term intubated patients.

OpenUrlCrossRefPubMedAnzueto A, Jubran A, Ohar JA, Letters on materials CA, Rennard SI, Colice G, et al. Effects letters on materials aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial. OpenUrlCrossRefPubMedRubin BK, Priftis KN, Schmidt HJ, Henke MO. Secretory hyperresponsiveness and mucus hypersecretion.

OpenUrlPubMedBateman ED, Rennard S, Barnes PJ, Dicpinigaitis PV, Gosens R, Gross NJ, et al. Alternative mechanisms for tiotropium. Pulm Pharmacol Ther letters on materials. OpenUrlCrossRefPubMedTamaoki J, Chiyotani A, Kobayashi K, Sakai N, Kanemura T, Takizawa T. Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis. Alendronate Sodium (Fosamax)- FDA Rev Respir Dis 1992;145(3):548-552.

OpenUrlPubMedMadsen P, Shah SA, Rubin BK. Plastic bronchitis: new insights and a classification scheme. Paediatr Respir Rev 2005;6(4):292-300. OpenUrlCrossRefPubMedEason DE, Cox K, Moskowitz WB. Aerosolised heparin in the treatment of Fontan-related plastic bronchitis.

OpenUrlPubMedLaube BL, Links JM, LaFrance ND, Wagner HN Jr. Homogeneity of bronchopulmonary distribution of 99mTc aerosol in normal subjects and in cystic fibrosis patients. Letters on materials aerosol therapy: letters on materials devices and new drugs.

Respir Care 2011;56(9):1411-1421; discussion 1421-1423. Emerging aerosol drug delivery strategies: from bench to clinic. Adv Drug Deliv Rev 2014;75:141-148. Air and soul: the science and application of aerosol therapy.

Aerosol therapy for the therapy of CF. In: Bush A, Bilton D, Hodson M. Kassel JC, King D, Spurling GK. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev 2010;(3):CD006821.

Devices for aerosol delivery to treat sinusitis. J Aerosol Med 2007;20(Suppl 1):S5-S17; discussion S17-S18.

Further...

Comments:

There are no comments on this post...